Research Brokerage Updates: Community Health Systems, Inc. (NYSE:CYH), Hologic, Inc. (NASDAQ:HOLX)

For the current quarter, analysts are expecting Community Health Systems, Inc. (NYSE:CYH) to report EPS of $0.08. This consensus estimate is provided by Zacks Research. After the period that ended on 2016-12-31, Community Health Systems, Inc. (NYSE:CYH) reported an EPS actual of $0.46. The difference between the actual and estimate resulted in a surprise factor of 283.33%. The company is expected to release their next earnings report on or around 2017-05-01. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Community Health Systems, Inc. (NYSE:CYH) have a current ABR or average broker rating of 3.06. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Community Health Systems, Inc. (NYSE:CYH) is $9.785. The top analyst target is $18, and the lowest target is $5 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

In the most recent session, Hologic, Inc. (NASDAQ:HOLX) shares have traded +0.31%. Following the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent review, the stock has been noted $1.72 away from the 50-day moving average of $40.96 and $3.32 away from the 200-day moving average of $39.36. From a different angle, the stock has been recently recorded -0.67% off of the 52-week high of 42.97 and +30.76% removed from the 52-week low of 32.64. 

Currently, Hologic, Inc. has a price to earnings ratio of 36.48. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio below one, it may be viewed as undervalued. If a company has a PEG Ratio above one, it may show that the company is overvalued. A PEG Ratio near one may be viewed as fair value. The stock currently has a PEG Ratio of 2.02.

Price Target Update

Analysts polled by Thomson Reuters have set a consensus target price of $45.93 on shares. Target prices may vary from one analyst to another due to the various ways they may proceed to calculate future price targets. This is a near-term estimation for the next 12-18 months.

Leave a Comment